Hausmann, Oliver

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: Yes

Yes

Jörg, L; Pecaric-Petkovic, T; Reichenbach, S; Coslovsky, M; Stalder, O; Pichler, W; Hausmann, O (2018). Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients. Clinical and experimental allergy, 48(2), pp. 196-204. Blackwell Scientific Publications 10.1111/cea.13066

Hoffmann, H J; Santos, A F; Mayorga, C; Nopp, A; Eberlein, B; Ferrer, M; Rouzaire, P; Ebo, D G; Sabato, V; Sanz, M L; Pecaric-Petkovic, T; Patil, S U; Hausmann, Oliver; Shreffler, W G; Korosec, P; Knol, E F (2015). The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy, 70(11), pp. 1393-1405. Wiley-Blackwell 10.1111/all.12698

Fux, Michaela; Pecaric-Petkovic, T.; Odermatt, A.; Hausmann, Oliver; Lorentz, A.; Bischoff, S. C.; Virchow, J. C.; Dahinden, Clemens A. (2014). IL-33 is a mediator rather than a trigger of the acute allergic response in humans. Allergy, 69(2), pp. 216-222. Wiley-Blackwell 10.1111/all.12309

Hausmann, Oliver; Manigold, Tobias (2013). Biologika – Genese und Charakteristika immunvermittelter Nebenwirkungen. Allergologie, 36(10), pp. 452-459. Dustri-Verlag

Provide Feedback